Clearmind Medicine receives Johns Hopkins approval for CMND-100 trial parts May 26, 2026 08:25AM
Clearmind Medicine files Hong Kong patent for depression therapy combo Mar 13, 2026 07:46AM
Clearmind Medicine reports positive safety data from CMND-100 trial Feb 9, 2026 08:17AM
Clearmind Medicine receives approval to continue phase I trial Nov 24, 2025 08:51AM
Clearmind Medicine files patent for obesity and liver disease therapy Jul 30, 2025 08:21AM


Apr 16, 2025 08:40AM Clearmind Medicine (CMND) Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
Mar 18, 2025 07:32AM Clearmind Medicine (CMND) Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients
Jan 6, 2025 08:15AM Clearmind Medicine (CMND) Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment